Accurate identification of HLA-B*15:02 allele by two-dimensional polymerase chain reaction

被引:2
|
作者
Zhu, Xueting [1 ]
Yu, Yang [1 ]
Zhang, Jun [1 ]
Zhan, Yuxia [1 ]
Luo, Guanghua [1 ]
Zheng, Lu [1 ]
机构
[1] Soochow Univ, Clin Med Res Ctr, Affiliated Hosp 3, Changzhou, Peoples R China
关键词
2D-PCR; HLA-B*15:02; Genotyping; STEVENS-JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; HLA CLASS-I; CUTANEOUS ADVERSE-REACTIONS; DRUG-REACTIONS; RISK-FACTOR; CARBAMAZEPINE; ASSOCIATION; HAN; POPULATION;
D O I
10.1016/j.cca.2023.117654
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: HLA-B*15:02 is highly associated with carbamazepine-induced SJS/TEN; however, there is no rapid and accurate detecting method. Here, we present a method to distinguish HLA-B*15:02 from 16 highly homologous HLA-B*15 alleles.Methods: The high-throughput two-dimensional polymerase chain reaction (2D-PCR) technology was employed to identify HLA-B*15:02 in two-tube reaction. And, 2D-PCR accuracy was verified by PCR-sequence based typing (PCR-SBT).Results: HLA-B*15:02 heterozygotes were identified by 14 melting valleys in the first tube reaction and none in the second, or by 13 melting valleys in the first tube reaction and one in the second. HLA-B*15:02 homozygote was identified by 13 melting valleys in the first tube reaction and none in the second. Three (0.16%) HLA-B*15:02 homozygotes and 84 (4.59%) HLA-B*15:02 heterozygotes were detected in 1830 samples of clinical general population without detecting 16 highly homologous alleles to HLA-B*15:02. The kappa test showed 100% coincidence between the 2D-PCR and PCR-SBT.Conclusions: 2D-PCR in two-tube reaction method for identifying HLA-B*15:02 was successfully established. Identification of HLA-B*15:02 is necessary prior to taking CBZ based on HLA-B*15:02 allele frequency.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Temporal trends and patterns in carbamazepine use, related severe cutaneous adverse reactions, and HLA-B*15:02 screening: A nationwide study
    Lin, Chih-Wan
    Huang, Wei-I
    Chao, Pi-Hui
    Chen, Wen-Wen
    Hsiao, Fei-Yuan
    EPILEPSIA, 2018, 59 (12) : 2325 - 2339
  • [42] Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B*35:02 as a risk factor
    Urban, Thomas Jacob
    Nicoletti, Paola
    Chalasani, Naga
    Serrano, Jose
    Stolz, Andrew
    Daly, Ann K.
    Aithal, Guruprasad P.
    Dillon, John
    Navarro, Victor
    Odin, Joseph
    Barnhart, Huiman
    Ostrov, David
    Long, Nanye
    Cirulli, Elizabeth Trilby
    Watkins, Paul Brent
    Fontana, Robert John
    JOURNAL OF HEPATOLOGY, 2017, 67 (01) : 137 - 144
  • [43] Association of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients
    Capule, Francis
    Tragulpiankit, Pramote
    Mahasirimongkol, Surakameth
    Jittikoon, Jiraphun
    Wichukchinda, Nuanjun
    Theresa Alentajan-Aleta, Lara
    James Barit, Jay-, V
    Casanova-Gutierrez, Josephine
    Cabral-Lim, Leonor
    Baltazar Reyes, Jose Paciano
    Roa, Francisca
    Salonga, Raymark
    Faith San Gabriel, Katrina
    Lynn Silao, Catherine
    PHARMACOGENOMICS JOURNAL, 2020, 20 (03): : 533 - 541
  • [44] Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
    Tiwattanon, Kanyawan
    John, Shobana
    Koomdee, Napatrupron
    Jinda, Pimonpan
    Rachanakul, Jiratha
    Jantararoungtong, Thawinee
    Nuntharadthanaphong, Nutthan
    Kloypan, Chiraphat
    Biswas, Mohitosh
    Boongird, Apisit
    Sukasem, Chonlaphat
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [45] Awareness of HLA-B* 15:02 screening in trigeminal neuralgia and the gene screening policy among dentists in Southern Thailand
    Saepoo, Jirayu
    Pangsomboon, Kanokporn
    Tianviwat, Sukanya
    SPECIAL CARE IN DENTISTRY, 2023, 43 (02) : 286 - 293
  • [46] HLA-B*15:02 screening in epileptic patients using a high resolution melting- real time PCR (HRM-QPCR) method
    Rani, Zam Zureena Mohd
    Murad, Nor Azian Abdul
    Then, Sue-Mian
    Bernam, Suthashini Panja
    Abdullah, Asmaa
    Saimun, Saberi
    Othman, Sri Noraima
    Ali, Raymond Azman
    Jamal, Rahman
    NEUROLOGY ASIA, 2018, 23 (02) : 137 - 144
  • [47] Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care
    Sung, Cynthia
    Tan, Liesbet
    Limenta, Michael
    Ganesan, Ganga
    Toh, Dorothy
    Chan, Cheng Leng
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [48] Comparison of a New In-House and Three Published HLA-B*15:02 Screening Methods for Prevention of Carbamazepine-Induced Severe Drug Reactions
    Jaruthamsophon, Kanoot
    Sripo, Thanya
    Sukasem, Chonlaphat
    Limprasert, Pornprot
    PLOS ONE, 2016, 11 (05):
  • [49] Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes
    Kuse, Nozomi
    Murakoshi, Hayato
    Akahoshi, Tomohiro
    Chikata, Takayuki
    James, Katherine L.
    Gatanaga, Hiroyuki
    Rowland-Jones, Sarah L.
    Oka, Shinichi
    Takiguchi, Masafumi
    JOURNAL OF VIROLOGY, 2021, 95 (23)
  • [50] Genotypes at rs2844682 and rs3909184 have no clinical value in identifying HLA-B*15:02 carriers
    Guang-dan Zhu
    Ashley A. Brenton
    Alka Malhotra
    Bae J. Riley
    Katherine E. Church
    Frank G. Espin
    Tanya A. Moreno
    Jennifer M. Strickland
    Andria L. Del Tredici
    European Journal of Clinical Pharmacology, 2015, 71 : 1021 - 1023